$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Alkyl-substituted cellulose-based sustained-release oral drug dosage forms 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-009/22
  • A61K-009/52
출원번호 US-0453144 (1995-05-30)
발명자 / 주소
  • Shell John W. (Hillsborough CA)
출원인 / 주소
  • Depomed, Inc. (Foster City CA 02)
인용정보 피인용 횟수 : 145  인용 특허 : 0

초록

Sustained release oral drug dosage forms that comprise a tablet or capsule containing a plurality of particles of a solid-state drug dispersed in alkyl cellulose such as hydroxyethylcellulose or hydroxypropylcellulose. Once ingested the tablet or capsule disintegrates to disperse the particles into

대표청구항

A sustained release oral drug dosage form for releasing a solution of a drug into the stomach comprising a plurality of solid particles of initially about 3-9 mm in diameter in maximum dimension, each particle containing a solid-state drug dispersed within a non-chemically crosslinked alkyl-substitu

이 특허를 인용한 특허 (145)

  1. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  2. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  3. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  4. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai; Chow, San-Laung; Lin, Edward; Wong, David, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  5. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B., Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  6. Robert R. Whittle ; Frederick D. Sancilio ; Grayson Walker Stowell ; Douglas John Jenkins ; Linda B. Whittall, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  7. Robert R. Whittle ; Frederick D. Sancilio ; Grayson Walker Stowell ; Douglas John Jenkins ; Linda B. Whittall, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  8. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John, Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  9. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same.
  10. Storm, Kevin H.; Conley, Creighton P.; Roush, John A., Amoxicillin and potassium clavulanate dosage form.
  11. Campos, Sebastien Andre; Harling, John David; Miah, Afjal Hussain; Smith, Ian Edward David, Benzothiophene derivatives as estrogen receptor inhibitors.
  12. Peter Timmins GB; Andrew B. Dennis GB; Kiren A. Vyas GB, Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
  13. Baron, Alain D.; Brown, Martin R.; Jones, Christopher R. G.; Fineman, Mark S., Chemosensory receptor ligand-based therapies.
  14. Baron, Alain; Brown, Martin R.; Jones, Christopher R. G., Chemosensory receptor ligand-based therapies.
  15. Baron, Alain; Brown, Martin R.; Jones, Christopher R. J., Chemosensory receptor ligand-based therapies.
  16. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  17. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia.
  18. Kay,Robert A.; Thomas,Larry K.; Bogue,Beuford A., Composition and method for maintaining healthy mobile joints and cartilage.
  19. Kay, Robert A.; Thomas, Larry K.; Bogue, Beuford A., Composition and method for treatment of conditions having an inflammatory component.
  20. Storm, Kevin H.; Conley, Creighton P.; Roush, John A., Composition comprising amoxicillin and potassium clavulanate.
  21. Sharma, Vinay K.; Hussain, Javed; Khorakiwala, Habil F., Composition for pulsatile delivery of diltiazem and process of manufacture.
  22. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan.
  23. Campos, Sebastien Andre; Harling, John David, Compounds.
  24. Cheng, Xiu Xiu; Jan, Steve; Chou, Joseph; Chen, Chih-Ming, Controlled release metformin formulations.
  25. Giovanni Sanso IT, Double capsule for the administration of active principles in multiple therapies.
  26. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Fontana Steven A., Dry blend pharmaceutical formulations.
  27. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Dry blend pharmaceutical formulations.
  28. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B., Dry blend pharmaceutical unit dosage form.
  29. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda D., Dry-blend pharmaceutical formulations.
  30. Lim, Jong; Shell, John N.; Louie-Helm, Jenny, Dual drug dosage forms with improved separation of drugs.
  31. Lim, Jong; Shell, John N.; Louie-Helm, Jenny, Dual drug dosage forms with improved separation of drugs.
  32. Lim, Jong; Shell, John N.; Louie-Helm, Jenny, Dual drug dosage forms with improved separation of drugs.
  33. William J. Sandborn, Enema and enterically-coated oral dosage forms of azathioprine.
  34. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Extended-release minocycline dosage forms.
  35. John W. Shell ; Jenny Louie-Helm ; Micheline Markey, Extending the duration of drug release within the stomach during the fed mode.
  36. Shell, John W.; Louie-Helm, Jenny; Markey, Micheline, Extending the duration of drug release within the stomach during the fed mode.
  37. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker, FT-Raman spectroscopic measurement.
  38. Fushimi, Nobuhiko; Fujikura, Hideki; Isaji, Masayuki, Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof.
  39. Berner, Bret; Hou, Sui Yuen Eddie, Gastric retained gabapentin dosage form.
  40. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M, Gastric retained gabapentin dosage form.
  41. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  42. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  43. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  44. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  45. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  46. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Gastric retained gabapentin dosage form.
  47. Wong, Patrick S.-L.; Edgren, David E., Gastric retaining oral liquid dosage form.
  48. Edgren, David E.; Jao, Francisco; Wong, Patrick S. -L., Gastric retention dosage form having multiple layers.
  49. Devarakonda, Krishna R.; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  50. Devarakonda, Krishna; Guiliani, Michael J; Gupta, Vishal K; Heasley, Ralph A; Shelby, Susan, Gastric retentive extended release pharmaceutical compositions.
  51. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  52. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  53. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  54. Han, Chien-Hsuan; Hou, Sui Yuen Eddie; Reid, Monica L., Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic.
  55. Berner, Bret; Hou, Sui Yuen Eddie; Gana, Theophilus J.; Cramer, Marilou S., Gastric retentive gabapentin dosage forms and methods for using same.
  56. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  57. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  58. Hou, Sui Yuen Eddie, Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders.
  59. Hou, Sui Yuen Eddie, Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders.
  60. Hou, Sui Yuen Eddie, Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders.
  61. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for minocycline.
  62. Mohammad, Hassan, Gastroretentive drug delivery system comprising an extruded hydratable polymer.
  63. Muthusamy, Ramesh; Kulkarni, Mohan Gopalkrishna, Gastroretentive, extended release composition of therapeutic agent.
  64. Whittle, Robert R.; Sancilio, Frederick D.; Stowell, Grayson Walker; Jenkins, Douglas John; Whittall, Linda B., Granulated pharmaceutical formulations and methods for making the same.
  65. Adusumilli Prasad S. ; Sivapragasam Vimala, Method and composition for increasing calcium uptake.
  66. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Method for the treatment of acne and certain dosage forms thereof.
  67. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan, Method of improving bioavailability.
  68. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Method of preparing sustained-release preparations of quinolone antibiotics.
  69. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Method of treating a bacterial infection.
  70. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate.
  71. Timmins, Peter; Dennis, Andrew B.; Vyas, Kiren A., Method of use of a biphasic controlled release delivery system for high solubility pharmaceuticals and method.
  72. Flore Stephen G. ; Dellamary Luis A. ; Reeve Lorraine E. ; Weers Jeffry G., Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions.
  73. Ghatnekar, Gautam S.; Brower, Justin, Methods and compositions for the treatment of metabolic disorders.
  74. Mailland, Federico, Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof.
  75. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  76. Park, Jae Han; Eisenhauer, Tiffani; Dhanarajan, Anish; Gupta, Vishal K.; Overholt, Stephen, Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans.
  77. Williams, Jonnie R., Methods of providing anti-inflammation support.
  78. Trotti, Davide; Pasinelli, Piera; Jablonski, Michael R., Methods of treating a neurodegenerative disease in a mammal in need thereof.
  79. Jonas, Jeffrey; Bose, Anjana; Tsai, Joyce, Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion.
  80. Lee, Ronald D.; Vakily, Majid; Mulford, Darcy; Wu, Jing-Tao; Atkinson, Stuart, Methods of treating gastrointestinal disorders independent of the intake of food.
  81. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage.
  82. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  83. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  84. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  85. Berner, Bret; Hou, Sui Yuen Eddie; Gusler, Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  86. Berner,Bret; Hou,Sui Yuen Eddie; Gusler,Gloria M., Methods of treatment using a gastric retained gabapentin dosage.
  87. Berner, Bret; Hou, Sui Yuen Eddie, Methods of treatment using a gastric retained gabapentin dosage form.
  88. Devane,John; Cumming,K. Iain; Hou,Sui Yuen Eddie; Gusler,Gloria M., Methods of treatment using a gastric retained losartan dosage.
  89. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  90. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  91. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  92. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  93. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  94. Rastogi, Suneel K.; Rao, Niranjan; Periclou, Antonia; Abramowitz, Wattanaporn; Dedhiya, Mahendra G.; Mahashabde, Shashank, Modified release formulations of memantine oral dosage forms.
  95. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Modified release pharmaceutical formulation comprising amoxycillin.
  96. Conley, Creighton P.; Roush, John A.; Storm, Kevin H., Modified release pharmaceutical formulation comprising amoxycillin.
  97. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  98. Miller, Fred H., Multi-phase, multi-compartment capsular delivery apparatus and methods for using same.
  99. Miller, Fred H., Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same.
  100. Taneja, Rajneesh; Vakilynejad, Majid, Multiple PPI dosage form.
  101. Taneja, Rajneesh; Vakilynejad, Majid, Multiple PPI dosage form.
  102. Taneja, Rajneesh; Vakilynejad, Majid, Multiple PPI dosage form.
  103. Williams, Jonnie R.; Wright, Curtis, Nutraceutical product containing anatabine and yerba maté.
  104. Scaffidi, James, Nutritional supplement and use thereof.
  105. Chao Shouchung,TWX ; Tseng Wen-Pao,TWX ; Chang Hui-Fang,TWX ; Chen David,TWX ; Lu Shu-Bin,TWX, Oral cisapride dosage forms with an extended duration.
  106. Sachs George ; Dietrich Rango,DEX, Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole.
  107. Sachs George ; Dietrich Rango,DEX, Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole.
  108. Sachs George ; Dietrich Rango,DEX, Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole.
  109. Depui, Helene; Lundberg, Per, Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID.
  110. Depui,Helene; Lundberg,Per, Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID.
  111. Talwar, Naresh; Sen, Himadri; Staniforth, John N., Orally administered drug delivery system providing temporal and spatial control.
  112. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  113. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia.
  114. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  115. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  116. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  117. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  118. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  119. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  120. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  121. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  122. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  123. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  124. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  125. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  126. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  127. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  128. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  129. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  130. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  131. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  132. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  133. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan, Pharmaceutical formulations.
  134. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Fontana Steven A., Pharmaceutical unit dosage form.
  135. Whittle Robert R. ; Sancilio Frederick D. ; Stowell Grayson Walker ; Jenkins Douglas John ; Whittall Linda B. ; Meyer Glenn Alan ; Fontana Steven A., Pharmaceutical unit dosage form.
  136. Sharma, Vinay K., Preparation of micron-size pharmaceutical particles by microfluidization.
  137. Wong Patrick S. L. ; Dong Liang-Chang ; Edgren David E. ; Theeuwes Felix ; Gardner Phyllis I. ; Jao Francisco ; Wan Jason J., Prolonged release active agent dosage form adapted for gastric retention.
  138. Storm,Kevin H.; Conley,Creighton P.; Roush,John A., Second release phase formulation.
  139. Pevzner, Victor; Moses-Heller, Sheera, Stable orally disintegrating pharmaceutical compositions.
  140. Nirmal Mulye ; Kavita Inamdar IN, Sustained release tablet containing hydrocolloid and cellulose ether.
  141. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Stab, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics.
  142. Kanikanti, Venkata-Rangarao; Rupp, Roland; Weber, Wolfgang; Deuringer, Peter; Henck, Jan-Olav; Staβ, Heino; Nishioka, Takaaki; Katakawa, Yoshifumi; Taniguchi, Chika; Ichihashi, Hitoshi, Sustained-release preparations of quinolone antibiotics and method for preparation thereof.
  143. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  144. Devarakonda, Krishna; Giuliani, Michael J.; Gupta, Vishal K.; Heasley, Ralph A.; Shelby, Susan, Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia.
  145. Sandborn William J., Use of topical azathioprine and thioguanine to treat colorectal adenomas.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로